These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 1379760)

  • 1. DNA analysis of peripheral blood mononuclear cells for early detection of hepatic graft rejection.
    Taki J; Nakajima Y; Hisanaga M; Kanehiro H; Nakano H
    Transplant Proc; 1992 Aug; 24(4):1609-10. PubMed ID: 1379760
    [No Abstract]   [Full Text] [Related]  

  • 2. [DNA analysis of peripheral blood mononuclear cells for early detection of hepatic graft rejection].
    Taki J; Nakajima Y; Hisanaga M; Kanehiro H; Nakano H
    Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):801-8. PubMed ID: 8377755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An increase in spontaneous proliferation of peripheral blood mononuclear cells in the early phase after liver transplantation--a useful indication of acute rejection.
    Kato H; Inamoto T; Uyama S; Kanaya S; Yamauchi A; Uemoto S; Tanaka K; Ozawa K
    Transplantation; 1992 Dec; 54(6):1125-9. PubMed ID: 1465785
    [No Abstract]   [Full Text] [Related]  

  • 4. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.
    Langer A; Valdivia LA; Murase N; Woo J; Celli S; Fung JJ; Starzl TE; Demetris AJ
    Am J Pathol; 1993 Jul; 143(1):85-98. PubMed ID: 7686346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
    Woodle ES; So S; Jendrisak MD; Perdrizet GA; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1988-9. PubMed ID: 7682358
    [No Abstract]   [Full Text] [Related]  

  • 6. Spontaneous proliferation of peripheral blood mononuclear cells as an indicator for insufficient plasma levels of FK 506 in the early phase after liver transplantation.
    Kato H; Inamoto T; Kanaya S; Uyama S; Uemoto S; Tanaka K; Yamaoka Y
    Transplant Proc; 1994 Apr; 26(2):893-5. PubMed ID: 7513481
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of long-term liver allograft survival by delayed immunosuppression is dependent on interleukin-10.
    Yang ZF; Ngai P; Lau CK; Ho DW; Tam KH; Lam CT; Poon RT; Fan ST
    Liver Transpl; 2007 Apr; 13(4):571-8. PubMed ID: 17394163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK 506 rescue therapy: early conversion improves efficacy.
    Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1990-1. PubMed ID: 7682359
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced incidence of acute, refractory acute, and chronic rejection after liver transplantation with FK506-based immunosuppression. European FK506 Multicentre Liver Study Group.
    Transplant Proc; 1994 Dec; 26(6):3260-3. PubMed ID: 7527960
    [No Abstract]   [Full Text] [Related]  

  • 10. The pattern of rejection and susceptibility to different kinds of immunosuppression after combined liver, duodenum, and pancreas transplantation in swine--immunosuppressive drugs versus ex vivo immunomodulation of the allograft.
    Saito S; Fujiwara T; Sakagami K; Kobayashi N; Takaishi Y; Orita K
    Transplant Proc; 1995 Feb; 27(1):518-9. PubMed ID: 7533420
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of protection from humoral rejection by a xenografted liver.
    Celli S; Valdivia LA; Kelly RH; Sun H; Tsugita M; Pan F; Rao AS; Demetris AJ; Fung JJ; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):300-2. PubMed ID: 7533395
    [No Abstract]   [Full Text] [Related]  

  • 12. Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.
    Wiesner RH; Porayko MK; Wahlstrom HE; Gores GJ; Kamath PS; Hay JE; Krom RA
    Transplant Proc; 1993 Apr; 25(2):1791-3. PubMed ID: 7682352
    [No Abstract]   [Full Text] [Related]  

  • 13. FK506: inhibition of humoral mechanisms of hepatic allograft rejection.
    Woodle ES; Perdrizet GA; Brunt EM; So SK; Jendrisak MD; McCullough CS; Vehe KL; White HM; Peters MG; Mohanakumar T
    Transplantation; 1992 Aug; 54(2):377-81. PubMed ID: 1379749
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytoimmunologic monitoring using DNA analysis in canine liver transplantation.
    Nakajima Y; Hisanaga M; Taki J; Kanehiro H; Nakano H
    Transplantation; 1993 Mar; 55(3):480-3. PubMed ID: 8456464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease.
    Mueller AR; Platz KP; Bechstein WO; Blumhardt G; Lobeck H; Hop U; Neuhaus P
    Transplant Proc; 1994 Dec; 26(6):3637-9. PubMed ID: 7527984
    [No Abstract]   [Full Text] [Related]  

  • 16. The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A.
    Mueller AR; Platz KP; Blumhardt G; Bechstein WO; Steinmüller T; Christe W; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1995 Feb; 27(1):1117-20. PubMed ID: 7533359
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation between mRNA expression level of multidrug resistance 1/ABCB1 in blood cells and required level of tacrolimus in pediatric living-donor liver transplantation.
    Goto M; Masuda S; Kiuchi T; Ogura Y; Oike F; Tanaka K; Uemoto S; Inui K
    J Pharmacol Exp Ther; 2008 May; 325(2):610-6. PubMed ID: 18252812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity of FK 506 in liver transplant recipients.
    Frank B; Perdrizet GA; White HM; Marsh JW; Lemann W; Woodle ES
    Transplant Proc; 1993 Apr; 25(2):1887-8. PubMed ID: 7682355
    [No Abstract]   [Full Text] [Related]  

  • 19. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
    Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
    [No Abstract]   [Full Text] [Related]  

  • 20. Spontaneous proliferation of peripheral blood lymphocytes as an indicator of intragraft immune activation in liver transplant patients.
    Kiuchi T; Kato H; Kanaya S; Nashan B; Schlitt HJ; Inamoto T; Ringe B; Ozawa K; Pichlmayr R
    Clin Transplant; 1994 Aug; 8(4):382-7. PubMed ID: 7949544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.